knowledge -WSS

knowledge

author：Wikipedia 2025-09-07 06:46:41 - browse：75

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Democrats decry new health bill for going easy on private equity

WSS

The explosion of genetic testing requires a new approach

STAT Summit: Michael J. Fox on progress in Parkinson's research

Senate panel puts off hardest PBM reforms for another day

Studies point to risks of excluding people with obesity from drug trials

Hospital price transparency does save money, advocate argues

Pharmacists can make shortage drugs, but at what cost?

hotspot

knowledge

focus

Duchenne breakthrough therapy leaves behind pioneering families

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

In age of alternative facts, a scholarly course on calling out crap

What it's like to live with paralysis for one psychologist

Wildfire smoke exposes gaps in outdoor worker protections

Eli Lilly expects to double planned employment in Boston center

Sports medicine is finally prioritizing gender equality

FDA warns J&J's Abiomed: We will regulate your software

23andMe had bad news about my health. I wish a person had delivered it

CEOs share strategies for surviving biotech slump

Wikipedia

FDA warns J&J's Abiomed: We will regulate your software

What it's like to live with paralysis for one psychologist

HHS leader on health, climate change and biopharma emissions

Hospital price transparency does save money, advocate argues

CDC Director Mandy Cohen on transparency, trust, and health

First Opinion Podcast: Long Covid needs a new approach

explore

Wikipedia

hotspot

knowledge